<DOC>
	<DOCNO>NCT02744833</DOCNO>
	<brief_summary>This study evaluate safety profile GMI-1271 effect thrombus resolution patient distal calf vein Deep Venous Thrombosis ( DVT ) .</brief_summary>
	<brief_title>Study Assess Safety , Tolerability , Efficacy GMI-1271 Patients With Calf-level Deep Venous Thrombosis ( DVT )</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Age 1875 year Male female Diagnosed acute isolated calf vein Deep Venous Thrombosis ( DVT ) Willing able participate require evaluation procedure study protocol History presence clinically significant medical condition disease opinion principal investigator Uncontrolled acute lifethreatening bacterial , viral fungal infection Unable treat systemic anticoagulant Current use immunosuppressant , antiplatelets ( aspirin ) , anticoagulant , and/or antiepileptic Diagnosis acute leukemia multiple myeloma undergo active treatment maintenance treatment within past 5 year Current recent cancer treatment Major surgery within 21 day plan surgery study period Female subject pregnant breastfeed Known history HIV , Hepatitis B Hepatitis C Alcoholism drug use Clinically significant cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>DVT</keyword>
</DOC>